Amgen, which has been beefing up its U.S. manufacturing operations, sold its stake in Turkey’s oldest pharmaceutical company Gensenta to the Eczacıbaşı Group for...
The acquisition includes Teneobio's proprietary bispecific and multispecific antibody technologies, which will enable significant acceleration and efficiency in the discovery and development of new molecules.